Results 221 to 230 of about 2,120 (245)

Interleukin‐18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin‐1 Inhibitors

open access: yesArthritis &Rheumatology, EarlyView.
Objective To evaluate the prognostic utility of circulating interleukin‐18 (IL‐18) levels in predicting disease activity, macrophage activation syndrome (MAS), and disease course in patients with Still disease (SD) receiving first‐line IL‐1 inhibitors (IL‐1i).
Matteo Trevisan   +8 more
wiley   +1 more source

Gastroenterological disorders in inborn errors of immunity. Part 1. Epidemiology, classification, symptoms, diagnosis, and treatment. [PDF]

open access: yesPrz Gastroenterol
Napiórkowska-Baran K   +7 more
europepmc   +1 more source

Secondary antibody deficiencies in the modern era: emerging trends, diagnostic pitfalls, and advances in personalised management. [PDF]

open access: yesFront Immunol
Elkhalifa S   +7 more
europepmc   +1 more source

Ecology and impacts of white-nose syndrome on bats

Nature Reviews Microbiology, 2021
Joseph R Hoyt   +2 more
exaly  

Guillain-Barré syndrome

Lancet, The, 2021
Nortina Shahrizaila   +2 more
exaly  

Enhancing global access to cancer medicines

Ca-A Cancer Journal for Clinicians, 2020
Javier Cortes   +2 more
exaly  

Recent progress in Lynch syndrome and other familial colorectal cancer syndromes

Ca-A Cancer Journal for Clinicians, 2018
Patrick M Boland   +2 more
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Home - About - Disclaimer - Privacy